Nsg533 exam 3 - Study guides, Class notes & Summaries

Exam 1: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam Review | Complete Guide with Questions and Verified Answers | 100% Correct - Wilkes Q: What are the goals set by ACE /ACCE and are they written in stone for all patients? Answer: Primary target for glycemic control is HbA1C Individualize HbA1C goal - based on...Duration of DM Age /life expectancy Comorbid conditions Known CVD or advanced comorbid conditionsHypoglycemic unawareness Individual patient considerations Q:...

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025) Advanced Pharmacology Review | Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: NSAID use Nonselective COX-1 and COX-2 inhibitors (COX-2 does anti-inflammation) Precaution: GI issues, renal toxicity, antiplatelet effect No NSAID is better than others- but vary from patient to patient Best for: RA, menstrual cramps, postsurgical pain, bony metastasis Flat-dose curve response: higher doses aren't more effective than moderate doses b...

Exam 3: NSG533/ NSG 533 (New 2023/ 2024 Update) Advanced Pharmacology Exam Review| Guide with Questions and Verified Answers| 100% Correct QUESTION how to treat hypertension a. Step 1: ACE inhibitor or ARB or CCB or thiazide diuretic b. Step 2: ACE inhibitor or ARB + CCB or thiazide diuretic c. Step 3: ACE inhibitor or ARB + CCB + thiazide diuretic Step 4: ACE inhibitor or ARB + CCB + thiazide diuretic + spironolactone QUESTION Avoid CCB in patients with Answer: hea...

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam | Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: When are ACEIs or ARBs added in treatment of CS/carotid artery disease? Answer: When thiazide diuretics and CCBs fail to achieve treatment goals. Q: When do you start anti-platelet therapy in patients with CS/carotid artery disease? Answer: Symptomatic for 21 days or more Q: What medication and dose are preferred anti-platelet's for CS/carotid art...

Exam 3: NSG533/ NSG 533 (Latest 2023/ 2024 Update) Advanced Pharmacology Exam Review| Guide with Questions and Verified Answers| 100% Correct Q: Short-acting muscarinic antagonist (SAMA) Answer: Ipratropium Q: avoid co administration of ICS with which CYP3A4 inhibitors? (may cause cushing's) Answer: ritonavir, itraconazole, ketoconazole Q: lack of response to ICS may be indicative of what? Answer: CLCCl1 gene Q: LABAs Answer: Salmeterol Formotero...

NSG533 / NSG 533 EXAM 3 2024/2025 | QUESTIONS WITH 100% VERIFIED ANSWERS AND COMPREHENSIVE RATIONALES | GRADED A+

NSG533 / NSG 533 Exam 3 (Latest 2024 / 2025): Advanced Pharmacology | Questions and Verified Answers | 100% Correct | Grade A - Wilkes

Exam 3 :NSG 533 | NSG533 Questions and Answers Graded A+ | Latest 2024 | Wilkes Exam 3 :NSG 533 | NSG533 Questions and Answers Graded A+ | Latest 2024 | Wilkes

Exam 1: NSG533/ NSG 533 (Latest 2023/ 2024 Update) Advanced Pharmacology Exam| Questions and Verified Answers with Rationales| 100% Correct| Grade A Q: In order to determine how much T4 replacement a patient needs to re-establish a euthyroid state, the NP considers: 1. the TSH value 2. the patient's T4 3. the patient's body weight 4. the patient's gender Answer: 3. the patient's body weight Replacement is based on body weight and is usually calculated in kg. The patients we...